Design and release characteristics of sustained release tablet containing metformin HCl

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 44, Issue 3, 2008, Pages 477-483

  Basak, Subal Chandra ^a   Kumar, Kesevan Senthil ^a   Ramalingam, Murugesan ^b  

^a ANNAMALAI UNIVERSITY   (India)

^b Fourrts India Laboratories Pvt Ltd   (India)

Author keywords

Drugs sustained release; Higuchi's equation; Hydrophobic matrices; Kinetic model; Metformin HCl

Indexed keywords

HEXADECANOL; METFORMIN; PROPOLIS;

ARTICLE; DRUG FORMULATION; DRUG GRANULATION; MATRIX TABLET; SUSTAINED RELEASE PREPARATION; TABLET HARDNESS; THICKNESS;

EID: 55849092494     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-93322008000300018     Document Type: Article

References (25)

1. AHFS Drug Information. 45.ed. Bethesda, Maryland: American Society of Health-System Pharmacists, 2003a. p. 3016.
2. AHFS Drug Information. 45. ed. Bethesda, American Society of Health-System Pharmacists, 2003b. p. 3026.
3. AULTON, M. E. Pharmaceutics: the science of dosage form design. 1. ed. London: Churchill Livinstone, 1998. p. 247.
4. BALASUBRAMANIAM, J.; RAO, V.U.; VASUDHA, M.; BABU, J; RAJINIKANTH, P. S. Sodium alginate microspheres of metformin HCl: Formulation and in vitro evaluation. Curr. Drug Deliv., Brisbane, v. 4, p. 249-56, 2007.
5. BASAK, S.C.; NAGESWARARAO, K.; MANAVALAN, R.; RAMARAO, P. Development and in vitro evaluation of an oral floating matrix tablet formulation of ciprofloxacin. Indian J. Pharm. Sci., Mumbai, v.66, p.313-316, 2004.
6. BASAK, S.C.; RAHMAN, J.; RAMALINGAM, M. Design and in vitro testing of a floatable gastroretentive tablet of metformin hydrochloride. Pharmazie, Eschborn, v.62, p.145-148, 2007.
7. CARR, R.L. Evaluating the flow properties of solids. Chem. Eng. Sci, New York, v.72, p.163, 1965.
8. CARTER, S.J. Cooper and Gunn's: Tutorial pharmacy. 6. ed. Delhi: CBS Publishers and Distributors, 1986. p. 225.
9. DAKKURI, A.; BUTLER, L.D.; DELUCA, P.P. Sustained release from inert matrices II: effect of surfactants on tripellanamine hydrochloride release. J. Pharm. Sci., Washington, v.67, p.334-357, 1978.
10. DI COLO, G.; ZAMBITO, Y.; BAGGIANI, A.; CARELLI, V.; SERAFINI, M.F.A site-specific controlled-release system for metformin. J. Pharm. Pharmacol., London, v.57, p.565-571, 2005.
11. GIBALDI, M.; FELDMAN, S. Establishment of sink conditions in dissolution rate determinations- theoretical considerations and application to non-disintegrating dosage forms. J. Pharm. Sci., Washington, v.56, p.1238-1242, 1967.
12. GOODHART, F.W.; MCCOY, R.H.; NINGER, F.C. Release of a water-soluble drug from a wax matrix timed-release tablet. J. Pharm. Sci., Washington, v.63, p.1748-1751, 1974.
13. HIGUCHI, T. Mechanism of sustained release medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci., Washington, v.52, p.1145-1149, 1963.
14. HU, L. D.; LIU, Y.; TANG, X.; ZHANG, Q. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets. Eur. J. Pharm. Biopharm., Amsterdam, v.64, p.185-92, 2006.
15. INDIAN PHARMACOPOEIA. 4.ed. New Delhi: The Controller of Publications, 1996a. v.1, p.470.
16. INDIAN PHARMACOPOEIA. 4.ed. New Delhi: The Controller of Publications, 1996b. v. II, p. 736.
17. KORSMEYER, R.W.; GUNNY, R.; PEPPAS, N.A. Mechanism of solute release from hydrophilic polymers. Int. J. Pharm., Amsterdam, v.15, p.25-35, 1983.
18. PEPPAS, N.A. Analysis of fickian and non-fickian drug release from polymers. Pharm. Acta Helv., Zurich, v.60, p.110-111, 1985.
19. PETERLIN, A. Diffusion with discontinuous swelling. VI Type II diffusion in spherical particles. Polym. Eng. Sci., Storrs, v.20, p.238-243, 1980.
20. REZA, M.S.; QUADIR, M.A.; HAIDER, S.S. Development of theophylline sustained release dosage form based on kollidon SR. Pak. J. Pharm Sci., Karashi, v.15, p.63-70, 2002.
21. SCHEEN, A.J. Clinical pharmacokinetics of metformin. Clin. Pharmacokinet., Auckland, v.30, p.359-371, 1996.
22. SHAH, D.; SHAH, Y.; RAMPRADHAN, M. Development and evaluation of controlled release diltiazem hydrochloride microspheres using cross linked poly vinyl alcohol. Drug Dev. Ind. Pharm., New York, v.23, p.567-574, 1997.
23. SWEETMAN, C. Martindale. The Complete Drug Reference. 33. ed. London: The Pharmaceutical Press, 2002. p.332.
24. WAGNER, J.G. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J. Pharm. Sci., Washington, v.58, p.1253-1257, 1969.
25. UNITED STATES PHARMACOPOEIA. 24. ed. United States Pharmacopeial Convention Inc. Rockville: 2000. p.1942.